Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Phase III Randomized Trial of Prostate Only or Whole Pelvic RadioTherapy in High Risk Prostate Cancer (POP-RT) Trial

NCT02302105 is registered in ClinicalTrials.gov with Tata Memorial Centre as lead sponsor.

NCT NCT02302105
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02302105 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Phase III Randomized Trial of Prostate Only or Whole Pelvic RadioTherapy in High Risk Prostate Cancer (POP-RT) Trial
Lead sponsor
Tata Memorial Centre
Phase
Not applicable
Overall status
Active, not recruiting
Start date
November 25, 2011
Completion date
October 23, 2026
Enrollment
224 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer